216 related articles for article (PubMed ID: 38594685)
1. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for a type III hybrid effectiveness-implementation trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care.
Beidas RS; Ahmedani BK; Linn KA; Marcus SC; Johnson C; Maye M; Westphal J; Wright L; Beck AL; Buttenheim AM; Daley MF; Davis M; Elias ME; Jager-Hyman S; Hoskins K; Lieberman A; McArdle B; Ritzwoller DP; Small DS; Wolk CB; Williams NJ; Boggs JM
Implement Sci; 2021 Sep; 16(1):89. PubMed ID: 34551811
[TBL] [Abstract][Full Text] [Related]
6. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
[TBL] [Abstract][Full Text] [Related]
7. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia.
Ajufo E; deGoma EM; Raper A; Yu KD; Cuchel M; Rader DJ
Genet Med; 2021 Sep; 23(9):1697-1704. PubMed ID: 34040191
[TBL] [Abstract][Full Text] [Related]
9. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
[TBL] [Abstract][Full Text] [Related]
10. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
[TBL] [Abstract][Full Text] [Related]
11. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
Wald DS; Bestwick JP
Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
13. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
14. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
15. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
[TBL] [Abstract][Full Text] [Related]
16. Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA.
Miller DM; Gaviglio A; Zierhut HA
Public Health Genomics; 2021; 24(3-4):110-122. PubMed ID: 33853081
[TBL] [Abstract][Full Text] [Related]
17. Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.
Jones LK; Gidding SS; Seaton TL; Goldberg A; Gregor C; Sturm AC; Brownson RC; Rahm AK; Williams MS
Res Social Adm Pharm; 2020 Mar; 16(3):390-395. PubMed ID: 31229402
[TBL] [Abstract][Full Text] [Related]
18. Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: a summary of the evidence.
Allison M
J Cardiovasc Nurs; 2015; 30(4):E1-E12. PubMed ID: 24831729
[TBL] [Abstract][Full Text] [Related]
19. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
